nodes	percent_of_prediction	percent_of_DWPC	metapath
Tiagabine—Decreased Central Nervous System Disorganized Electrical Activity—Topiramate—obesity	0.485	1	CiPCiCtD
Tiagabine—bipolar disorder—Topiramate—obesity	0.295	1	CpDpCtD
Tiagabine—CYP3A4—Sibutramine—obesity	0.0246	0.27	CbGbCtD
Tiagabine—CYP3A4—Benzphetamine—obesity	0.0186	0.204	CbGbCtD
Tiagabine—CYP3A4—Bupropion—obesity	0.0158	0.174	CbGbCtD
Tiagabine—CYP3A4—Orlistat—obesity	0.0129	0.142	CbGbCtD
Tiagabine—CYP3A4—Cimetidine—obesity	0.0116	0.127	CbGbCtD
Tiagabine—CYP3A4—Topiramate—obesity	0.00761	0.0834	CbGbCtD
Tiagabine—SLC6A1—hindbrain—obesity	0.00176	0.459	CbGeAlD
Tiagabine—SLC6A1—pituitary gland—obesity	0.000731	0.19	CbGeAlD
Tiagabine—SLC6A1—endocrine gland—obesity	0.000566	0.147	CbGeAlD
Tiagabine—SLC6A1—liver—obesity	0.00051	0.133	CbGeAlD
Tiagabine—SLC6A1—NRF2 pathway—G6PD—obesity	0.000337	0.00981	CbGpPWpGaD
Tiagabine—SLC6A1—Neuronal System—GABRA6—obesity	0.000333	0.00971	CbGpPWpGaD
Tiagabine—CYP3A4—Liver X Receptor Pathway—SCD—obesity	0.000326	0.00949	CbGpPWpGaD
Tiagabine—SLC6A1—Transmission across Chemical Synapses—GLUL—obesity	0.00031	0.00903	CbGpPWpGaD
Tiagabine—SLC6A1—Monoamine Transport—IL1B—obesity	0.00028	0.00817	CbGpPWpGaD
Tiagabine—SLC6A1—SLC-mediated transmembrane transport—SLC9A3—obesity	0.00028	0.00816	CbGpPWpGaD
Tiagabine—SLC6A1—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A4—obesity	0.000275	0.00802	CbGpPWpGaD
Tiagabine—SLC6A1—NRF2 pathway—GPX3—obesity	0.000273	0.00796	CbGpPWpGaD
Tiagabine—SLC6A1—SLC-mediated transmembrane transport—HK2—obesity	0.000267	0.00778	CbGpPWpGaD
Tiagabine—SLC6A1—SLC-mediated transmembrane transport—SLC27A1—obesity	0.000256	0.00746	CbGpPWpGaD
Tiagabine—SLC6A1—Transmembrane transport of small molecules—AQP7—obesity	0.000248	0.00722	CbGpPWpGaD
Tiagabine—SLC6A1—Neuronal System—GLUL—obesity	0.000238	0.00692	CbGpPWpGaD
Tiagabine—SLC6A1—NRF2 pathway—SLC6A4—obesity	0.000229	0.00667	CbGpPWpGaD
Tiagabine—SLC6A1—Transmission across Chemical Synapses—SLC22A1—obesity	0.000229	0.00666	CbGpPWpGaD
Tiagabine—SLC6A1—Transmembrane transport of small molecules—SLC16A7—obesity	0.000227	0.0066	CbGpPWpGaD
Tiagabine—SLC6A1—Transmembrane transport of small molecules—LCN2—obesity	0.000211	0.00614	CbGpPWpGaD
Tiagabine—SLC6A1—SLC-mediated transmembrane transport—HK1—obesity	0.00021	0.00611	CbGpPWpGaD
Tiagabine—SLC6A1—NRF2 pathway—NQO1—obesity	0.000207	0.00603	CbGpPWpGaD
Tiagabine—SLC6A1—Monoamine Transport—TNF—obesity	0.000204	0.00593	CbGpPWpGaD
Tiagabine—SLC6A1—Neuronal System—KCNMA1—obesity	0.000201	0.00584	CbGpPWpGaD
Tiagabine—SLC6A1—NRF2 pathway—SLC2A4—obesity	0.000199	0.00578	CbGpPWpGaD
Tiagabine—SLC6A1—Transmembrane transport of small molecules—COX7C—obesity	0.000198	0.00577	CbGpPWpGaD
Tiagabine—SLC6A1—NRF2 pathway—GGT1—obesity	0.000192	0.0056	CbGpPWpGaD
Tiagabine—CYP3A4—Estrogen metabolism—STS—obesity	0.000189	0.00551	CbGpPWpGaD
Tiagabine—CYP3A4—Benzo(a)pyrene metabolism—AKR1C3—obesity	0.000186	0.00542	CbGpPWpGaD
Tiagabine—SLC6A1—SLC-mediated transmembrane transport—SLC22A1—obesity	0.000185	0.0054	CbGpPWpGaD
Tiagabine—CYP3A4—Fatty Acid Omega Oxidation—ADH1B—obesity	0.000182	0.00531	CbGpPWpGaD
Tiagabine—SLC6A1—Transmembrane transport of small molecules—GABRA6—obesity	0.000179	0.00522	CbGpPWpGaD
Tiagabine—SLC6A1—Transmembrane transport of small molecules—FTL—obesity	0.000179	0.00522	CbGpPWpGaD
Tiagabine—CYP3A4—Drug Induction of Bile Acid Pathway—NR1I3—obesity	0.000177	0.00514	CbGpPWpGaD
Tiagabine—SLC6A1—Neuronal System—SLC22A1—obesity	0.000175	0.0051	CbGpPWpGaD
Tiagabine—SLC6A1—Transmembrane transport of small molecules—SLC6A14—obesity	0.000172	0.005	CbGpPWpGaD
Tiagabine—SLC6A1—NRF2 pathway—HMOX1—obesity	0.00017	0.00496	CbGpPWpGaD
Tiagabine—SLC6A1—Transmission across Chemical Synapses—BCHE—obesity	0.000169	0.00492	CbGpPWpGaD
Tiagabine—CYP3A4—Liver X Receptor Pathway—SREBF1—obesity	0.000164	0.00476	CbGpPWpGaD
Tiagabine—CYP3A4—Farnesoid X Receptor  Pathway—NR0B2—obesity	0.000162	0.00471	CbGpPWpGaD
Tiagabine—CYP3A4—Drug Induction of Bile Acid Pathway—NR1I2—obesity	0.000162	0.0047	CbGpPWpGaD
Tiagabine—SLC6A1—SLC-mediated transmembrane transport—GCK—obesity	0.000161	0.00469	CbGpPWpGaD
Tiagabine—CYP3A4—Liver X Receptor Pathway—FASN—obesity	0.000156	0.00453	CbGpPWpGaD
Tiagabine—SLC6A1—Transmembrane transport of small molecules—SLC9A3—obesity	0.000142	0.00415	CbGpPWpGaD
Tiagabine—SLC6A1—Transmembrane transport of small molecules—HK2—obesity	0.000136	0.00396	CbGpPWpGaD
Tiagabine—SLC6A1—Transmission across Chemical Synapses—COMT—obesity	0.000135	0.00393	CbGpPWpGaD
Tiagabine—CYP3A4—Drug Induction of Bile Acid Pathway—SULT2A1—obesity	0.000134	0.0039	CbGpPWpGaD
Tiagabine—SLC6A1—Transmission across Chemical Synapses—GNB3—obesity	0.000133	0.00388	CbGpPWpGaD
Tiagabine—SLC6A1—Transmembrane transport of small molecules—SLC27A1—obesity	0.00013	0.00379	CbGpPWpGaD
Tiagabine—SLC6A1—Neuronal System—BCHE—obesity	0.000129	0.00377	CbGpPWpGaD
Tiagabine—SLC6A1—SLC-mediated transmembrane transport—SLC2A4—obesity	0.000125	0.00364	CbGpPWpGaD
Tiagabine—CYP3A4—Farnesoid X Receptor  Pathway—SULT2A1—obesity	0.000122	0.00357	CbGpPWpGaD
Tiagabine—CYP3A4—Irinotecan Pathway—BCHE—obesity	0.000118	0.00345	CbGpPWpGaD
Tiagabine—CYP3A4—Tamoxifen metabolism—SULT2A1—obesity	0.000113	0.00329	CbGpPWpGaD
Tiagabine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARD—obesity	0.000111	0.00324	CbGpPWpGaD
Tiagabine—SLC6A1—Transmembrane transport of small molecules—TRPV1—obesity	0.000111	0.00322	CbGpPWpGaD
Tiagabine—CYP3A4—digestive system—obesity	0.000107	0.0279	CbGeAlD
Tiagabine—SLC6A1—Transmembrane transport of small molecules—HK1—obesity	0.000107	0.0031	CbGpPWpGaD
Tiagabine—CYP3A4—Constitutive Androstane Receptor Pathway—NR1I3—obesity	0.000106	0.0031	CbGpPWpGaD
Tiagabine—SLC6A1—Neuronal System—COMT—obesity	0.000103	0.00301	CbGpPWpGaD
Tiagabine—CYP3A4—Fatty Acid Omega Oxidation—CYP2E1—obesity	0.000103	0.00299	CbGpPWpGaD
Tiagabine—SLC6A1—Neuronal System—GNB3—obesity	0.000102	0.00297	CbGpPWpGaD
Tiagabine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I3—obesity	0.000101	0.00295	CbGpPWpGaD
Tiagabine—SLC6A1—Transmission across Chemical Synapses—PRKCB—obesity	9.58e-05	0.00279	CbGpPWpGaD
Tiagabine—SLC6A1—Transmembrane transport of small molecules—SLC22A1—obesity	9.42e-05	0.00274	CbGpPWpGaD
Tiagabine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—obesity	9.28e-05	0.0027	CbGpPWpGaD
Tiagabine—CYP3A4—Estrogen metabolism—NQO1—obesity	9.24e-05	0.00269	CbGpPWpGaD
Tiagabine—CYP3A4—Oxidation by Cytochrome P450—CYB5A—obesity	9.02e-05	0.00263	CbGpPWpGaD
Tiagabine—CYP3A4—endocrine gland—obesity	8.86e-05	0.023	CbGeAlD
Tiagabine—SLC6A1—Transmembrane transport of small molecules—PRKAR2B—obesity	8.69e-05	0.00253	CbGpPWpGaD
Tiagabine—CYP3A4—Xenobiotics—CYP2E1—obesity	8.59e-05	0.0025	CbGpPWpGaD
Tiagabine—CYP3A4—Tamoxifen metabolism—CYP2E1—obesity	8.26e-05	0.00241	CbGpPWpGaD
Tiagabine—CYP3A4—Aflatoxin activation and detoxification—GGT1—obesity	8.22e-05	0.00239	CbGpPWpGaD
Tiagabine—SLC6A1—Transmembrane transport of small molecules—GCK—obesity	8.18e-05	0.00238	CbGpPWpGaD
Tiagabine—CYP3A4—Constitutive Androstane Receptor Pathway—SULT2A1—obesity	8.07e-05	0.00235	CbGpPWpGaD
Tiagabine—CYP3A4—liver—obesity	7.99e-05	0.0208	CbGeAlD
Tiagabine—CYP3A4—Tryptophan metabolism—ECHS1—obesity	7.97e-05	0.00232	CbGpPWpGaD
Tiagabine—SLC6A1—Transmembrane transport of small molecules—CETP—obesity	7.89e-05	0.0023	CbGpPWpGaD
Tiagabine—SLC6A1—Transmembrane transport of small molecules—TF—obesity	7.8e-05	0.00227	CbGpPWpGaD
Tiagabine—CYP3A4—Estrogen metabolism—COMT—obesity	7.75e-05	0.00226	CbGpPWpGaD
Tiagabine—CYP3A4—Tryptophan metabolism—HADH—obesity	7.49e-05	0.00218	CbGpPWpGaD
Tiagabine—SLC6A1—Transmembrane transport of small molecules—TFRC—obesity	7.48e-05	0.00218	CbGpPWpGaD
Tiagabine—SLC6A1—Neuronal System—PRKCB—obesity	7.34e-05	0.00214	CbGpPWpGaD
Tiagabine—CYP3A4—Farnesoid X Receptor  Pathway—PPARGC1A—obesity	7.32e-05	0.00213	CbGpPWpGaD
Tiagabine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP26B1—obesity	7.23e-05	0.0021	CbGpPWpGaD
Tiagabine—CYP3A4—Oxidation by Cytochrome P450—CYP26B1—obesity	7.13e-05	0.00208	CbGpPWpGaD
Tiagabine—SLC6A1—NRF2 pathway—TGFB1—obesity	6.47e-05	0.00188	CbGpPWpGaD
Tiagabine—SLC6A1—SLC-mediated transmembrane transport—ALB—obesity	6.45e-05	0.00188	CbGpPWpGaD
Tiagabine—SLC6A1—Transmembrane transport of small molecules—SLC2A4—obesity	6.36e-05	0.00185	CbGpPWpGaD
Tiagabine—SLC6A1—Transmembrane transport of small molecules—CYCS—obesity	6.28e-05	0.00183	CbGpPWpGaD
Tiagabine—SLC6A1—Transmembrane transport of small molecules—NCOA1—obesity	6.07e-05	0.00177	CbGpPWpGaD
Tiagabine—SLC6A1—Transmembrane transport of small molecules—PLG—obesity	5.91e-05	0.00172	CbGpPWpGaD
Tiagabine—CYP3A4—Phase 1 - Functionalization of compounds—CYP26B1—obesity	5.86e-05	0.00171	CbGpPWpGaD
Tiagabine—CYP3A4—Farnesoid X Receptor  Pathway—IRS2—obesity	5.71e-05	0.00166	CbGpPWpGaD
Tiagabine—Hyponatraemia—Topiramate—obesity	5.62e-05	0.000622	CcSEcCtD
Tiagabine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2E1—obesity	5.62e-05	0.00164	CbGpPWpGaD
Tiagabine—Anaemia—Sibutramine—obesity	5.61e-05	0.000621	CcSEcCtD
Tiagabine—Diplopia—Topiramate—obesity	5.6e-05	0.00062	CcSEcCtD
Tiagabine—Osteoarthritis—Topiramate—obesity	5.6e-05	0.00062	CcSEcCtD
Tiagabine—Agitation—Sibutramine—obesity	5.58e-05	0.000618	CcSEcCtD
Tiagabine—Disturbance in sexual arousal—Topiramate—obesity	5.56e-05	0.000615	CcSEcCtD
Tiagabine—Palpitations—Orlistat—obesity	5.55e-05	0.000614	CcSEcCtD
Tiagabine—Affect lability—Topiramate—obesity	5.51e-05	0.00061	CcSEcCtD
Tiagabine—Migraine—Topiramate—obesity	5.51e-05	0.00061	CcSEcCtD
Tiagabine—Nausea—Cimetidine—obesity	5.51e-05	0.00061	CcSEcCtD
Tiagabine—SLC6A1—Transmembrane transport of small molecules—GNB3—obesity	5.48e-05	0.0016	CbGpPWpGaD
Tiagabine—Malaise—Sibutramine—obesity	5.48e-05	0.000606	CcSEcCtD
Tiagabine—Cough—Orlistat—obesity	5.48e-05	0.000606	CcSEcCtD
Tiagabine—Psychotic disorder—Topiramate—obesity	5.47e-05	0.000605	CcSEcCtD
Tiagabine—Chills—Bupropion—obesity	5.46e-05	0.000604	CcSEcCtD
Tiagabine—Vertigo—Sibutramine—obesity	5.46e-05	0.000604	CcSEcCtD
Tiagabine—SLC6A1—Transmembrane transport of small molecules—HMOX1—obesity	5.46e-05	0.00159	CbGpPWpGaD
Tiagabine—Syncope—Sibutramine—obesity	5.45e-05	0.000603	CcSEcCtD
Tiagabine—Leukopenia—Sibutramine—obesity	5.44e-05	0.000602	CcSEcCtD
Tiagabine—Face oedema—Topiramate—obesity	5.41e-05	0.000598	CcSEcCtD
Tiagabine—Alopecia—Bupropion—obesity	5.38e-05	0.000595	CcSEcCtD
Tiagabine—Palpitations—Sibutramine—obesity	5.37e-05	0.000594	CcSEcCtD
Tiagabine—Irritability—Topiramate—obesity	5.35e-05	0.000592	CcSEcCtD
Tiagabine—Myalgia—Orlistat—obesity	5.34e-05	0.000591	CcSEcCtD
Tiagabine—Chest pain—Orlistat—obesity	5.34e-05	0.000591	CcSEcCtD
Tiagabine—Loss of consciousness—Sibutramine—obesity	5.34e-05	0.000591	CcSEcCtD
Tiagabine—SLC6A1—Transmembrane transport of small molecules—GNAS—obesity	5.34e-05	0.00155	CbGpPWpGaD
Tiagabine—CYP3A4—Constitutive Androstane Receptor Pathway—NCOA1—obesity	5.34e-05	0.00155	CbGpPWpGaD
Tiagabine—Urinary retention—Topiramate—obesity	5.33e-05	0.000589	CcSEcCtD
Tiagabine—Anxiety—Orlistat—obesity	5.33e-05	0.000589	CcSEcCtD
Tiagabine—Mood swings—Topiramate—obesity	5.31e-05	0.000587	CcSEcCtD
Tiagabine—Cough—Sibutramine—obesity	5.3e-05	0.000586	CcSEcCtD
Tiagabine—Discomfort—Orlistat—obesity	5.28e-05	0.000584	CcSEcCtD
Tiagabine—Ataxia—Topiramate—obesity	5.27e-05	0.000583	CcSEcCtD
Tiagabine—Hypertension—Sibutramine—obesity	5.24e-05	0.00058	CcSEcCtD
Tiagabine—SLC6A1—Transmembrane transport of small molecules—APOB—obesity	5.23e-05	0.00152	CbGpPWpGaD
Tiagabine—Dry mouth—Orlistat—obesity	5.23e-05	0.000578	CcSEcCtD
Tiagabine—Flatulence—Bupropion—obesity	5.22e-05	0.000577	CcSEcCtD
Tiagabine—Dehydration—Topiramate—obesity	5.21e-05	0.000576	CcSEcCtD
Tiagabine—Tension—Bupropion—obesity	5.2e-05	0.000575	CcSEcCtD
Tiagabine—Dysgeusia—Bupropion—obesity	5.19e-05	0.000574	CcSEcCtD
Tiagabine—Liver function test abnormal—Topiramate—obesity	5.17e-05	0.000572	CcSEcCtD
Tiagabine—Myalgia—Sibutramine—obesity	5.17e-05	0.000572	CcSEcCtD
Tiagabine—Chest pain—Sibutramine—obesity	5.17e-05	0.000572	CcSEcCtD
Tiagabine—Arthralgia—Sibutramine—obesity	5.17e-05	0.000572	CcSEcCtD
Tiagabine—Anxiety—Sibutramine—obesity	5.15e-05	0.00057	CcSEcCtD
Tiagabine—Nervousness—Bupropion—obesity	5.14e-05	0.000569	CcSEcCtD
Tiagabine—CYP3A4—Phase 1 - Functionalization of compounds—ADH1B—obesity	5.14e-05	0.0015	CbGpPWpGaD
Tiagabine—Oedema—Orlistat—obesity	5.12e-05	0.000567	CcSEcCtD
Tiagabine—Back pain—Bupropion—obesity	5.12e-05	0.000567	CcSEcCtD
Tiagabine—Orthostatic hypotension—Topiramate—obesity	5.12e-05	0.000566	CcSEcCtD
Tiagabine—Discomfort—Sibutramine—obesity	5.11e-05	0.000565	CcSEcCtD
Tiagabine—Hypokalaemia—Topiramate—obesity	5.1e-05	0.000564	CcSEcCtD
Tiagabine—Muscle spasms—Bupropion—obesity	5.09e-05	0.000563	CcSEcCtD
Tiagabine—Infection—Orlistat—obesity	5.09e-05	0.000563	CcSEcCtD
Tiagabine—Dry mouth—Sibutramine—obesity	5.06e-05	0.00056	CcSEcCtD
Tiagabine—Confusional state—Sibutramine—obesity	5e-05	0.000553	CcSEcCtD
Tiagabine—Tremor—Bupropion—obesity	4.96e-05	0.000549	CcSEcCtD
Tiagabine—Gastritis—Topiramate—obesity	4.96e-05	0.000549	CcSEcCtD
Tiagabine—Oedema—Sibutramine—obesity	4.96e-05	0.000548	CcSEcCtD
Tiagabine—Hyperhidrosis—Orlistat—obesity	4.95e-05	0.000548	CcSEcCtD
Tiagabine—Muscular weakness—Topiramate—obesity	4.94e-05	0.000547	CcSEcCtD
Tiagabine—Infection—Sibutramine—obesity	4.93e-05	0.000545	CcSEcCtD
Tiagabine—Ill-defined disorder—Bupropion—obesity	4.91e-05	0.000544	CcSEcCtD
Tiagabine—Anaemia—Bupropion—obesity	4.89e-05	0.000541	CcSEcCtD
Tiagabine—Shock—Sibutramine—obesity	4.88e-05	0.00054	CcSEcCtD
Tiagabine—Agitation—Bupropion—obesity	4.87e-05	0.000538	CcSEcCtD
Tiagabine—Thrombocytopenia—Sibutramine—obesity	4.85e-05	0.000537	CcSEcCtD
Tiagabine—Asthma—Topiramate—obesity	4.84e-05	0.000536	CcSEcCtD
Tiagabine—Dysphagia—Topiramate—obesity	4.84e-05	0.000536	CcSEcCtD
Tiagabine—Tachycardia—Sibutramine—obesity	4.84e-05	0.000535	CcSEcCtD
Tiagabine—CYP3A4—Constitutive Androstane Receptor Pathway—PPARGC1A—obesity	4.82e-05	0.0014	CbGpPWpGaD
Tiagabine—Hyperhidrosis—Sibutramine—obesity	4.79e-05	0.00053	CcSEcCtD
Tiagabine—Malaise—Bupropion—obesity	4.78e-05	0.000528	CcSEcCtD
Tiagabine—Vertigo—Bupropion—obesity	4.76e-05	0.000526	CcSEcCtD
Tiagabine—Syncope—Bupropion—obesity	4.75e-05	0.000525	CcSEcCtD
Tiagabine—Leukopenia—Bupropion—obesity	4.74e-05	0.000524	CcSEcCtD
Tiagabine—Anorexia—Sibutramine—obesity	4.73e-05	0.000523	CcSEcCtD
Tiagabine—Angina pectoris—Topiramate—obesity	4.72e-05	0.000522	CcSEcCtD
Tiagabine—Palpitations—Bupropion—obesity	4.68e-05	0.000518	CcSEcCtD
Tiagabine—Musculoskeletal discomfort—Orlistat—obesity	4.67e-05	0.000516	CcSEcCtD
Tiagabine—Bronchitis—Topiramate—obesity	4.66e-05	0.000515	CcSEcCtD
Tiagabine—Loss of consciousness—Bupropion—obesity	4.65e-05	0.000515	CcSEcCtD
Tiagabine—Insomnia—Orlistat—obesity	4.63e-05	0.000513	CcSEcCtD
Tiagabine—Hypotension—Sibutramine—obesity	4.63e-05	0.000512	CcSEcCtD
Tiagabine—Cough—Bupropion—obesity	4.62e-05	0.000511	CcSEcCtD
Tiagabine—Paraesthesia—Orlistat—obesity	4.6e-05	0.000509	CcSEcCtD
Tiagabine—Hypertension—Bupropion—obesity	4.57e-05	0.000506	CcSEcCtD
Tiagabine—Dysuria—Topiramate—obesity	4.53e-05	0.000501	CcSEcCtD
Tiagabine—Musculoskeletal discomfort—Sibutramine—obesity	4.52e-05	0.0005	CcSEcCtD
Tiagabine—Dyspepsia—Orlistat—obesity	4.51e-05	0.000499	CcSEcCtD
Tiagabine—Myalgia—Bupropion—obesity	4.51e-05	0.000499	CcSEcCtD
Tiagabine—Arthralgia—Bupropion—obesity	4.51e-05	0.000499	CcSEcCtD
Tiagabine—Chest pain—Bupropion—obesity	4.51e-05	0.000499	CcSEcCtD
Tiagabine—Anxiety—Bupropion—obesity	4.49e-05	0.000497	CcSEcCtD
Tiagabine—Insomnia—Sibutramine—obesity	4.48e-05	0.000496	CcSEcCtD
Tiagabine—Pollakiuria—Topiramate—obesity	4.47e-05	0.000495	CcSEcCtD
Tiagabine—Erectile dysfunction—Topiramate—obesity	4.46e-05	0.000493	CcSEcCtD
Tiagabine—Discomfort—Bupropion—obesity	4.45e-05	0.000493	CcSEcCtD
Tiagabine—Decreased appetite—Orlistat—obesity	4.45e-05	0.000493	CcSEcCtD
Tiagabine—Paraesthesia—Sibutramine—obesity	4.45e-05	0.000492	CcSEcCtD
Tiagabine—Dyspnoea—Sibutramine—obesity	4.42e-05	0.000489	CcSEcCtD
Tiagabine—Photosensitivity reaction—Topiramate—obesity	4.42e-05	0.000489	CcSEcCtD
Tiagabine—Fatigue—Orlistat—obesity	4.42e-05	0.000489	CcSEcCtD
Tiagabine—CYP3A4—Tryptophan metabolism—CYP2E1—obesity	4.41e-05	0.00129	CbGpPWpGaD
Tiagabine—Dry mouth—Bupropion—obesity	4.41e-05	0.000488	CcSEcCtD
Tiagabine—SLC6A1—Transmembrane transport of small molecules—PPARA—obesity	4.41e-05	0.00128	CbGpPWpGaD
Tiagabine—Somnolence—Sibutramine—obesity	4.41e-05	0.000488	CcSEcCtD
Tiagabine—Weight increased—Topiramate—obesity	4.41e-05	0.000488	CcSEcCtD
Tiagabine—Weight decreased—Topiramate—obesity	4.38e-05	0.000485	CcSEcCtD
Tiagabine—Pain—Orlistat—obesity	4.38e-05	0.000485	CcSEcCtD
Tiagabine—Hyperglycaemia—Topiramate—obesity	4.37e-05	0.000483	CcSEcCtD
Tiagabine—Dyspepsia—Sibutramine—obesity	4.36e-05	0.000483	CcSEcCtD
Tiagabine—Confusional state—Bupropion—obesity	4.36e-05	0.000482	CcSEcCtD
Tiagabine—CYP3A4—Constitutive Androstane Receptor Pathway—FOXO1—obesity	4.36e-05	0.00127	CbGpPWpGaD
Tiagabine—Pneumonia—Topiramate—obesity	4.34e-05	0.00048	CcSEcCtD
Tiagabine—Oedema—Bupropion—obesity	4.32e-05	0.000478	CcSEcCtD
Tiagabine—Decreased appetite—Sibutramine—obesity	4.31e-05	0.000477	CcSEcCtD
Tiagabine—Depression—Topiramate—obesity	4.3e-05	0.000476	CcSEcCtD
Tiagabine—Infection—Bupropion—obesity	4.29e-05	0.000475	CcSEcCtD
Tiagabine—Shock—Bupropion—obesity	4.25e-05	0.00047	CcSEcCtD
Tiagabine—Renal failure—Topiramate—obesity	4.24e-05	0.00047	CcSEcCtD
Tiagabine—Pain—Sibutramine—obesity	4.24e-05	0.000469	CcSEcCtD
Tiagabine—Constipation—Sibutramine—obesity	4.24e-05	0.000469	CcSEcCtD
Tiagabine—Neuropathy peripheral—Topiramate—obesity	4.23e-05	0.000468	CcSEcCtD
Tiagabine—Thrombocytopenia—Bupropion—obesity	4.23e-05	0.000468	CcSEcCtD
Tiagabine—Feeling abnormal—Orlistat—obesity	4.22e-05	0.000467	CcSEcCtD
Tiagabine—Tachycardia—Bupropion—obesity	4.22e-05	0.000467	CcSEcCtD
Tiagabine—Stomatitis—Topiramate—obesity	4.21e-05	0.000466	CcSEcCtD
Tiagabine—Urinary tract infection—Topiramate—obesity	4.2e-05	0.000464	CcSEcCtD
Tiagabine—Conjunctivitis—Topiramate—obesity	4.2e-05	0.000464	CcSEcCtD
Tiagabine—Gastrointestinal pain—Orlistat—obesity	4.19e-05	0.000463	CcSEcCtD
Tiagabine—Hyperhidrosis—Bupropion—obesity	4.18e-05	0.000462	CcSEcCtD
Tiagabine—SLC6A1—Transmembrane transport of small molecules—APOA1—obesity	4.14e-05	0.0012	CbGpPWpGaD
Tiagabine—Anorexia—Bupropion—obesity	4.12e-05	0.000456	CcSEcCtD
Tiagabine—Haematuria—Topiramate—obesity	4.12e-05	0.000455	CcSEcCtD
Tiagabine—Feeling abnormal—Sibutramine—obesity	4.09e-05	0.000452	CcSEcCtD
Tiagabine—Epistaxis—Topiramate—obesity	4.07e-05	0.000451	CcSEcCtD
Tiagabine—Urticaria—Orlistat—obesity	4.07e-05	0.00045	CcSEcCtD
Tiagabine—Gastrointestinal pain—Sibutramine—obesity	4.05e-05	0.000448	CcSEcCtD
Tiagabine—Sinusitis—Topiramate—obesity	4.05e-05	0.000448	CcSEcCtD
Tiagabine—Body temperature increased—Orlistat—obesity	4.05e-05	0.000448	CcSEcCtD
Tiagabine—Abdominal pain—Orlistat—obesity	4.05e-05	0.000448	CcSEcCtD
Tiagabine—Hypotension—Bupropion—obesity	4.04e-05	0.000447	CcSEcCtD
Tiagabine—Urticaria—Sibutramine—obesity	3.94e-05	0.000436	CcSEcCtD
Tiagabine—Musculoskeletal discomfort—Bupropion—obesity	3.94e-05	0.000436	CcSEcCtD
Tiagabine—CYP3A4—Tryptophan metabolism—CYP19A1—obesity	3.93e-05	0.00115	CbGpPWpGaD
Tiagabine—Abdominal pain—Sibutramine—obesity	3.92e-05	0.000434	CcSEcCtD
Tiagabine—Body temperature increased—Sibutramine—obesity	3.92e-05	0.000434	CcSEcCtD
Tiagabine—Insomnia—Bupropion—obesity	3.91e-05	0.000432	CcSEcCtD
Tiagabine—Haemoglobin—Topiramate—obesity	3.9e-05	0.000431	CcSEcCtD
Tiagabine—Rhinitis—Topiramate—obesity	3.89e-05	0.00043	CcSEcCtD
Tiagabine—Paraesthesia—Bupropion—obesity	3.88e-05	0.000429	CcSEcCtD
Tiagabine—Haemorrhage—Topiramate—obesity	3.88e-05	0.000429	CcSEcCtD
Tiagabine—Hypoaesthesia—Topiramate—obesity	3.86e-05	0.000427	CcSEcCtD
Tiagabine—Hallucination—Topiramate—obesity	3.86e-05	0.000427	CcSEcCtD
Tiagabine—Dyspnoea—Bupropion—obesity	3.85e-05	0.000426	CcSEcCtD
Tiagabine—Pharyngitis—Topiramate—obesity	3.85e-05	0.000426	CcSEcCtD
Tiagabine—Somnolence—Bupropion—obesity	3.84e-05	0.000425	CcSEcCtD
Tiagabine—Oedema peripheral—Topiramate—obesity	3.82e-05	0.000422	CcSEcCtD
Tiagabine—Dyspepsia—Bupropion—obesity	3.8e-05	0.000421	CcSEcCtD
Tiagabine—Hypersensitivity—Orlistat—obesity	3.77e-05	0.000418	CcSEcCtD
Tiagabine—Decreased appetite—Bupropion—obesity	3.76e-05	0.000416	CcSEcCtD
Tiagabine—Visual impairment—Topiramate—obesity	3.73e-05	0.000413	CcSEcCtD
Tiagabine—Fatigue—Bupropion—obesity	3.73e-05	0.000412	CcSEcCtD
Tiagabine—Constipation—Bupropion—obesity	3.7e-05	0.000409	CcSEcCtD
Tiagabine—Pain—Bupropion—obesity	3.7e-05	0.000409	CcSEcCtD
Tiagabine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—obesity	3.69e-05	0.00108	CbGpPWpGaD
Tiagabine—Asthenia—Orlistat—obesity	3.68e-05	0.000407	CcSEcCtD
Tiagabine—Hypersensitivity—Sibutramine—obesity	3.65e-05	0.000404	CcSEcCtD
Tiagabine—Pruritus—Orlistat—obesity	3.62e-05	0.000401	CcSEcCtD
Tiagabine—Tinnitus—Topiramate—obesity	3.61e-05	0.0004	CcSEcCtD
Tiagabine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2E1—obesity	3.57e-05	0.00104	CbGpPWpGaD
Tiagabine—Feeling abnormal—Bupropion—obesity	3.56e-05	0.000394	CcSEcCtD
Tiagabine—Asthenia—Sibutramine—obesity	3.56e-05	0.000394	CcSEcCtD
Tiagabine—Gastrointestinal pain—Bupropion—obesity	3.53e-05	0.000391	CcSEcCtD
Tiagabine—CYP3A4—Oxidation by Cytochrome P450—CYP2E1—obesity	3.52e-05	0.00103	CbGpPWpGaD
Tiagabine—Pruritus—Sibutramine—obesity	3.51e-05	0.000388	CcSEcCtD
Tiagabine—Diarrhoea—Orlistat—obesity	3.5e-05	0.000388	CcSEcCtD
Tiagabine—Chills—Topiramate—obesity	3.48e-05	0.000385	CcSEcCtD
Tiagabine—Urticaria—Bupropion—obesity	3.43e-05	0.00038	CcSEcCtD
Tiagabine—Alopecia—Topiramate—obesity	3.42e-05	0.000379	CcSEcCtD
Tiagabine—Body temperature increased—Bupropion—obesity	3.42e-05	0.000378	CcSEcCtD
Tiagabine—Abdominal pain—Bupropion—obesity	3.42e-05	0.000378	CcSEcCtD
Tiagabine—Diarrhoea—Sibutramine—obesity	3.39e-05	0.000375	CcSEcCtD
Tiagabine—Dizziness—Orlistat—obesity	3.39e-05	0.000375	CcSEcCtD
Tiagabine—Flatulence—Topiramate—obesity	3.32e-05	0.000368	CcSEcCtD
Tiagabine—Tension—Topiramate—obesity	3.31e-05	0.000366	CcSEcCtD
Tiagabine—Dysgeusia—Topiramate—obesity	3.3e-05	0.000366	CcSEcCtD
Tiagabine—Dizziness—Sibutramine—obesity	3.28e-05	0.000363	CcSEcCtD
Tiagabine—Nervousness—Topiramate—obesity	3.28e-05	0.000363	CcSEcCtD
Tiagabine—SLC6A1—Transmembrane transport of small molecules—ALB—obesity	3.28e-05	0.000954	CbGpPWpGaD
Tiagabine—Back pain—Topiramate—obesity	3.26e-05	0.000361	CcSEcCtD
Tiagabine—Vomiting—Orlistat—obesity	3.26e-05	0.00036	CcSEcCtD
Tiagabine—Muscle spasms—Topiramate—obesity	3.24e-05	0.000359	CcSEcCtD
Tiagabine—Rash—Orlistat—obesity	3.23e-05	0.000357	CcSEcCtD
Tiagabine—CYP3A4—Cytochrome P450 - arranged by substrate type—NCOA1—obesity	3.23e-05	0.00094	CbGpPWpGaD
Tiagabine—Dermatitis—Orlistat—obesity	3.23e-05	0.000357	CcSEcCtD
Tiagabine—Headache—Orlistat—obesity	3.21e-05	0.000355	CcSEcCtD
Tiagabine—Hypersensitivity—Bupropion—obesity	3.18e-05	0.000352	CcSEcCtD
Tiagabine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP19A1—obesity	3.18e-05	0.000926	CbGpPWpGaD
Tiagabine—Tremor—Topiramate—obesity	3.16e-05	0.00035	CcSEcCtD
Tiagabine—Vomiting—Sibutramine—obesity	3.15e-05	0.000349	CcSEcCtD
Tiagabine—CYP3A4—Oxidation by Cytochrome P450—CYP19A1—obesity	3.14e-05	0.000914	CbGpPWpGaD
Tiagabine—Ill-defined disorder—Topiramate—obesity	3.13e-05	0.000346	CcSEcCtD
Tiagabine—Rash—Sibutramine—obesity	3.13e-05	0.000346	CcSEcCtD
Tiagabine—Dermatitis—Sibutramine—obesity	3.12e-05	0.000345	CcSEcCtD
Tiagabine—Anaemia—Topiramate—obesity	3.12e-05	0.000345	CcSEcCtD
Tiagabine—CYP3A4—Biological oxidations—CYP26B1—obesity	3.11e-05	0.000906	CbGpPWpGaD
Tiagabine—Headache—Sibutramine—obesity	3.11e-05	0.000344	CcSEcCtD
Tiagabine—Asthenia—Bupropion—obesity	3.1e-05	0.000343	CcSEcCtD
Tiagabine—Agitation—Topiramate—obesity	3.1e-05	0.000343	CcSEcCtD
Tiagabine—CYP3A4—Metapathway biotransformation—CYP26B1—obesity	3.07e-05	0.000894	CbGpPWpGaD
Tiagabine—Pruritus—Bupropion—obesity	3.06e-05	0.000338	CcSEcCtD
Tiagabine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—obesity	3.05e-05	0.000889	CbGpPWpGaD
Tiagabine—Nausea—Orlistat—obesity	3.04e-05	0.000337	CcSEcCtD
Tiagabine—Malaise—Topiramate—obesity	3.04e-05	0.000337	CcSEcCtD
Tiagabine—Vertigo—Topiramate—obesity	3.03e-05	0.000335	CcSEcCtD
Tiagabine—Syncope—Topiramate—obesity	3.03e-05	0.000335	CcSEcCtD
Tiagabine—Leukopenia—Topiramate—obesity	3.02e-05	0.000334	CcSEcCtD
Tiagabine—Palpitations—Topiramate—obesity	2.98e-05	0.00033	CcSEcCtD
Tiagabine—Loss of consciousness—Topiramate—obesity	2.97e-05	0.000328	CcSEcCtD
Tiagabine—Diarrhoea—Bupropion—obesity	2.96e-05	0.000327	CcSEcCtD
Tiagabine—Nausea—Sibutramine—obesity	2.94e-05	0.000326	CcSEcCtD
Tiagabine—Cough—Topiramate—obesity	2.94e-05	0.000326	CcSEcCtD
Tiagabine—Hypertension—Topiramate—obesity	2.91e-05	0.000322	CcSEcCtD
Tiagabine—CYP3A4—Phase 1 - Functionalization of compounds—CYP2E1—obesity	2.89e-05	0.000842	CbGpPWpGaD
Tiagabine—Chest pain—Topiramate—obesity	2.87e-05	0.000318	CcSEcCtD
Tiagabine—Arthralgia—Topiramate—obesity	2.87e-05	0.000318	CcSEcCtD
Tiagabine—Myalgia—Topiramate—obesity	2.87e-05	0.000318	CcSEcCtD
Tiagabine—Anxiety—Topiramate—obesity	2.86e-05	0.000317	CcSEcCtD
Tiagabine—Dizziness—Bupropion—obesity	2.86e-05	0.000316	CcSEcCtD
Tiagabine—Discomfort—Topiramate—obesity	2.84e-05	0.000314	CcSEcCtD
Tiagabine—Dry mouth—Topiramate—obesity	2.81e-05	0.000311	CcSEcCtD
Tiagabine—Confusional state—Topiramate—obesity	2.78e-05	0.000307	CcSEcCtD
Tiagabine—Oedema—Topiramate—obesity	2.75e-05	0.000305	CcSEcCtD
Tiagabine—Vomiting—Bupropion—obesity	2.75e-05	0.000304	CcSEcCtD
Tiagabine—Infection—Topiramate—obesity	2.74e-05	0.000303	CcSEcCtD
Tiagabine—CYP3A4—Biological oxidations—ADH1B—obesity	2.73e-05	0.000794	CbGpPWpGaD
Tiagabine—Rash—Bupropion—obesity	2.73e-05	0.000301	CcSEcCtD
Tiagabine—Dermatitis—Bupropion—obesity	2.72e-05	0.000301	CcSEcCtD
Tiagabine—Shock—Topiramate—obesity	2.71e-05	0.0003	CcSEcCtD
Tiagabine—Headache—Bupropion—obesity	2.71e-05	0.0003	CcSEcCtD
Tiagabine—Thrombocytopenia—Topiramate—obesity	2.7e-05	0.000298	CcSEcCtD
Tiagabine—Tachycardia—Topiramate—obesity	2.69e-05	0.000297	CcSEcCtD
Tiagabine—Hyperhidrosis—Topiramate—obesity	2.66e-05	0.000294	CcSEcCtD
Tiagabine—Anorexia—Topiramate—obesity	2.62e-05	0.00029	CcSEcCtD
Tiagabine—CYP3A4—Phase 1 - Functionalization of compounds—NCOA1—obesity	2.62e-05	0.000762	CbGpPWpGaD
Tiagabine—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—obesity	2.58e-05	0.000751	CbGpPWpGaD
Tiagabine—Hypotension—Topiramate—obesity	2.57e-05	0.000285	CcSEcCtD
Tiagabine—Nausea—Bupropion—obesity	2.57e-05	0.000284	CcSEcCtD
Tiagabine—Musculoskeletal discomfort—Topiramate—obesity	2.51e-05	0.000278	CcSEcCtD
Tiagabine—Insomnia—Topiramate—obesity	2.49e-05	0.000276	CcSEcCtD
Tiagabine—Paraesthesia—Topiramate—obesity	2.47e-05	0.000274	CcSEcCtD
Tiagabine—Dyspnoea—Topiramate—obesity	2.45e-05	0.000272	CcSEcCtD
Tiagabine—Somnolence—Topiramate—obesity	2.45e-05	0.000271	CcSEcCtD
Tiagabine—Dyspepsia—Topiramate—obesity	2.42e-05	0.000268	CcSEcCtD
Tiagabine—Decreased appetite—Topiramate—obesity	2.39e-05	0.000265	CcSEcCtD
Tiagabine—Fatigue—Topiramate—obesity	2.37e-05	0.000263	CcSEcCtD
Tiagabine—Pain—Topiramate—obesity	2.35e-05	0.00026	CcSEcCtD
Tiagabine—Constipation—Topiramate—obesity	2.35e-05	0.00026	CcSEcCtD
Tiagabine—Feeling abnormal—Topiramate—obesity	2.27e-05	0.000251	CcSEcCtD
Tiagabine—Gastrointestinal pain—Topiramate—obesity	2.25e-05	0.000249	CcSEcCtD
Tiagabine—Urticaria—Topiramate—obesity	2.19e-05	0.000242	CcSEcCtD
Tiagabine—Body temperature increased—Topiramate—obesity	2.18e-05	0.000241	CcSEcCtD
Tiagabine—Abdominal pain—Topiramate—obesity	2.18e-05	0.000241	CcSEcCtD
Tiagabine—CYP3A4—Biological oxidations—SULT2A1—obesity	2.1e-05	0.000612	CbGpPWpGaD
Tiagabine—CYP3A4—Metapathway biotransformation—SULT2A1—obesity	2.07e-05	0.000604	CbGpPWpGaD
Tiagabine—Hypersensitivity—Topiramate—obesity	2.03e-05	0.000224	CcSEcCtD
Tiagabine—CYP3A4—Metapathway biotransformation—GPX3—obesity	1.98e-05	0.000576	CbGpPWpGaD
Tiagabine—Asthenia—Topiramate—obesity	1.98e-05	0.000219	CcSEcCtD
Tiagabine—Pruritus—Topiramate—obesity	1.95e-05	0.000216	CcSEcCtD
Tiagabine—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—obesity	1.91e-05	0.000557	CbGpPWpGaD
Tiagabine—Diarrhoea—Topiramate—obesity	1.88e-05	0.000208	CcSEcCtD
Tiagabine—Dizziness—Topiramate—obesity	1.82e-05	0.000201	CcSEcCtD
Tiagabine—Vomiting—Topiramate—obesity	1.75e-05	0.000194	CcSEcCtD
Tiagabine—Rash—Topiramate—obesity	1.74e-05	0.000192	CcSEcCtD
Tiagabine—Dermatitis—Topiramate—obesity	1.73e-05	0.000192	CcSEcCtD
Tiagabine—CYP3A4—Metapathway biotransformation—AKR1C3—obesity	1.73e-05	0.000505	CbGpPWpGaD
Tiagabine—Headache—Topiramate—obesity	1.72e-05	0.000191	CcSEcCtD
Tiagabine—Nausea—Topiramate—obesity	1.64e-05	0.000181	CcSEcCtD
Tiagabine—CYP3A4—Phase 1 - Functionalization of compounds—POMC—obesity	1.55e-05	0.000451	CbGpPWpGaD
Tiagabine—CYP3A4—Biological oxidations—CYP2E1—obesity	1.54e-05	0.000447	CbGpPWpGaD
Tiagabine—CYP3A4—Metapathway biotransformation—CYP2E1—obesity	1.52e-05	0.000441	CbGpPWpGaD
Tiagabine—CYP3A4—Biological oxidations—GGT1—obesity	1.41e-05	0.000411	CbGpPWpGaD
Tiagabine—CYP3A4—Biological oxidations—NCOA1—obesity	1.39e-05	0.000405	CbGpPWpGaD
Tiagabine—CYP3A4—Biological oxidations—CYP19A1—obesity	1.37e-05	0.000399	CbGpPWpGaD
Tiagabine—CYP3A4—Metapathway biotransformation—CYP19A1—obesity	1.35e-05	0.000393	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—CA3—obesity	1.28e-05	0.000373	CbGpPWpGaD
Tiagabine—CYP3A4—Biological oxidations—COMT—obesity	1.27e-05	0.000371	CbGpPWpGaD
Tiagabine—CYP3A4—Metapathway biotransformation—COMT—obesity	1.26e-05	0.000366	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—GLRX—obesity	1.09e-05	0.000317	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—OTC—obesity	9.71e-06	0.000283	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—PPM1L—obesity	9.71e-06	0.000283	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—INSIG2—obesity	9.71e-06	0.000283	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—ETFDH—obesity	9.71e-06	0.000283	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—GPT—obesity	8.88e-06	0.000259	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—INPP5E—obesity	8.88e-06	0.000259	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—UQCRC2—obesity	8.88e-06	0.000259	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—SUCLG2—obesity	8.26e-06	0.00024	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—ALDH6A1—obesity	8.26e-06	0.00024	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—ME1—obesity	8.26e-06	0.00024	CbGpPWpGaD
Tiagabine—CYP3A4—Biological oxidations—POMC—obesity	8.23e-06	0.00024	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—COX7C—obesity	7.76e-06	0.000226	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—UCP1—obesity	7.76e-06	0.000226	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—PNPLA3—obesity	7.76e-06	0.000226	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—DGAT2—obesity	7.36e-06	0.000214	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—CS—obesity	7.36e-06	0.000214	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—SUCLA2—obesity	7.36e-06	0.000214	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—CPS1—obesity	7.36e-06	0.000214	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—MUT—obesity	7.02e-06	0.000204	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—LIPE—obesity	7.02e-06	0.000204	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—CYB5A—obesity	6.73e-06	0.000196	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—DGAT1—obesity	6.73e-06	0.000196	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—ACLY—obesity	6.48e-06	0.000189	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—ALOX12—obesity	6.26e-06	0.000182	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—ENPP1—obesity	6.26e-06	0.000182	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—HMGCS1—obesity	6.06e-06	0.000176	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—PNPLA2—obesity	5.88e-06	0.000171	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—SAT1—obesity	5.88e-06	0.000171	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—PLIN1—obesity	5.88e-06	0.000171	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—ACADM—obesity	5.88e-06	0.000171	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—ANGPTL4—obesity	5.88e-06	0.000171	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—PFKFB3—obesity	5.88e-06	0.000171	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—OXCT1—obesity	5.72e-06	0.000167	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—ACACB—obesity	5.72e-06	0.000167	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—CYTB—obesity	5.72e-06	0.000167	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—PNLIP—obesity	5.58e-06	0.000162	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—SRD5A1—obesity	5.58e-06	0.000162	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—SDC3—obesity	5.44e-06	0.000159	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—CYP26B1—obesity	5.32e-06	0.000155	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—HK2—obesity	5.32e-06	0.000155	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—STS—obesity	5.32e-06	0.000155	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—PPARD—obesity	5.21e-06	0.000152	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—SLC27A1—obesity	5.1e-06	0.000149	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—FABP4—obesity	5e-06	0.000146	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—GLUL—obesity	5e-06	0.000146	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—UCP2—obesity	4.74e-06	0.000138	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—ECHS1—obesity	4.74e-06	0.000138	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—UCP3—obesity	4.74e-06	0.000138	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—HSD11B1—obesity	4.74e-06	0.000138	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—ADH1B—obesity	4.67e-06	0.000136	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—GPAM—obesity	4.59e-06	0.000134	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—ACSL1—obesity	4.59e-06	0.000134	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—PPARGC1B—obesity	4.59e-06	0.000134	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—FADS1—obesity	4.46e-06	0.00013	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—HADH—obesity	4.46e-06	0.00013	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—PCK1—obesity	4.46e-06	0.00013	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—ACP5—obesity	4.34e-06	0.000126	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—G6PD—obesity	4.23e-06	0.000123	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—SREBF2—obesity	4.18e-06	0.000122	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—HK1—obesity	4.18e-06	0.000122	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—LPA—obesity	4.03e-06	0.000117	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—LPIN1—obesity	3.95e-06	0.000115	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—APOA5—obesity	3.87e-06	0.000113	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—SLC22A1—obesity	3.69e-06	0.000107	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—CLOCK—obesity	3.69e-06	0.000107	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—SULT2A1—obesity	3.59e-06	0.000105	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—GLP1R—obesity	3.59e-06	0.000105	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—DPYD—obesity	3.54e-06	0.000103	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—PRKAR2B—obesity	3.4e-06	9.91e-05	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—DCN—obesity	3.38e-06	9.84e-05	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—CPT1A—obesity	3.29e-06	9.57e-05	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—NAMPT—obesity	3.22e-06	9.39e-05	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—LIPC—obesity	3.2e-06	9.33e-05	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—GCK—obesity	3.2e-06	9.33e-05	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—APOC3—obesity	3.18e-06	9.27e-05	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—CETP—obesity	3.09e-06	9e-05	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—SDC1—obesity	3.06e-06	8.9e-05	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—AKR1C3—obesity	3.01e-06	8.75e-05	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—SCARB1—obesity	2.96e-06	8.62e-05	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—SREBF1—obesity	2.87e-06	8.37e-05	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—GOT2—obesity	2.8e-06	8.14e-05	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—FASN—obesity	2.74e-06	7.96e-05	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—BCHE—obesity	2.72e-06	7.93e-05	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—CYP2E1—obesity	2.63e-06	7.65e-05	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—NQO1—obesity	2.6e-06	7.57e-05	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—SLC2A4—obesity	2.49e-06	7.25e-05	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—GCG—obesity	2.49e-06	7.25e-05	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—CYCS—obesity	2.46e-06	7.16e-05	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—GGT1—obesity	2.41e-06	7.03e-05	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—GOT1—obesity	2.41e-06	7.03e-05	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—NCOA1—obesity	2.38e-06	6.92e-05	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—STK11—obesity	2.34e-06	6.82e-05	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—CYP19A1—obesity	2.34e-06	6.82e-05	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—COMT—obesity	2.18e-06	6.34e-05	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—PPARGC1A—obesity	2.15e-06	6.25e-05	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—GNB3—obesity	2.15e-06	6.25e-05	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—HMOX1—obesity	2.14e-06	6.22e-05	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—GNAS—obesity	2.09e-06	6.09e-05	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—APOB—obesity	2.05e-06	5.96e-05	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—LPL—obesity	1.95e-06	5.69e-05	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—GPX1—obesity	1.91e-06	5.55e-05	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—CD36—obesity	1.86e-06	5.41e-05	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—MTHFR—obesity	1.76e-06	5.13e-05	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—PPARA—obesity	1.73e-06	5.03e-05	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—AGT—obesity	1.67e-06	4.87e-05	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—APOE—obesity	1.64e-06	4.77e-05	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—CAV1—obesity	1.62e-06	4.73e-05	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—APOA1—obesity	1.62e-06	4.72e-05	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—PIK3CG—obesity	1.48e-06	4.31e-05	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—PPARG—obesity	1.43e-06	4.16e-05	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—POMC—obesity	1.41e-06	4.1e-05	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—INS—obesity	1.4e-06	4.08e-05	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—PIK3CD—obesity	1.3e-06	3.79e-05	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—ALB—obesity	1.28e-06	3.74e-05	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—NOS3—obesity	1.23e-06	3.57e-05	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—PIK3R1—obesity	1.23e-06	3.57e-05	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—PIK3CB—obesity	1.13e-06	3.3e-05	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—PTGS2—obesity	1.12e-06	3.27e-05	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—PIK3CA—obesity	6.91e-07	2.01e-05	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—AKT1—obesity	5.64e-07	1.64e-05	CbGpPWpGaD
